An Open-Label, Single Dose Study to Determine the Metabolism and Excretion of [14C]E2086 in Healthy Male Participants
Eisai Inc.
Summary
The primary purpose of this study is to determine the metabolism and excretion of \[14C\]E2086 in healthy male participants.
Eligibility
- Age range
- 18–55 years
- Sex
- Male
- Healthy volunteers
- Yes
Inclusion Criteria: 1. Non-smoking and non-vaping, healthy male, age greater than or equal to (\>=) 18 years and less than or equal to (\<=) 55 years old at the time of informed consent 2. Body Mass Index (BMI) \>=18 and less than (\<) 30 kilogram per square meter (kg/m\^2) at Screening 3. Provide written informed consent 4. Willing and able to comply with all aspects of the protocol Exclusion Criteria: 1. Have previously been dosed in more than 2 radiolabeled drug studies in the past 12 months. For participants who have previously been dosed in 2 or more radiolabeled drug studies within th…
Interventions
- DrugE2086
E2086 oral capsule.
Location
- Fortrea Clinical Research Unit Inc.Madison, Wisconsin